Endovia Health Sciences (EDVA) EBT Margin Growth (3y) (2015 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) EBT Margin Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | 6,685.00 |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | -2,054.00 |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | - |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 8,006.00 |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 9,980.00 |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | -5,319.00 |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 31,363.00 |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -5.05 Mn |
| Dec 31, 2025 | 62,502.00 |
| Sep 30, 2025 | -240,470.00 |
| Jun 30, 2025 | 3.59 Mn |
| Mar 31, 2025 | -463,065.00 |
| Dec 31, 2024 | 29,837.00 |
| Sep 30, 2024 | 5,007.00 |
| Jun 30, 2024 | -21,238.00 |
| Mar 31, 2024 | -3,365.00 |
| Dec 31, 2023 | 106,696.00 |
| Sep 30, 2023 | 22,578.00 |
| Jun 30, 2023 | 1,936.00 |
| Mar 31, 2023 | 301,793.00 |
| Dec 31, 2022 | -108,089.00 |
| Sep 30, 2022 | -8,725.00 |
| Jun 30, 2022 | 12,068.00 |
| Mar 31, 2022 | 189,412.00 |
| Dec 31, 2021 | -22,315.00 |
| Sep 30, 2021 | -41,098.00 |
| Jun 30, 2021 | -21,868.00 |